4-iodophenyl isothiocyanate: a neuroprotective compound.

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Naturally occurring isothiocyanates (ITCs) exhibit known chemopreventive and neuroprotective activities.
• Synthetic ITCs represent a potential therapeutic avenue for neurodegenerative diseases.

Purpose of the Study:

• To investigate the neuroprotective and neurotrophic potential of synthetic 4-iodophenyl isothiocyanate (4-IPITC).
• To evaluate 4-IPITC efficacy in various in vitro and in vivo models of neurodegeneration.

Main Methods:

• In vitro: Primary cortical neurons exposed to glutamate, oxygen-glucose deprivation, oxidative stress, and MPP+.
• In vivo: Experimental autoimmune encephalomyelitis (EAE) in rats and a Parkinson's disease model (MPTP) in mice, treated with 4-IPITC.
• Behavioral and biochemical analyses were performed in animal models.

Main Results:

• 4-IPITC significantly reduced neuronal cell death across all in vitro assays.
• The compound displayed neurotrophic properties in neurite outgrowth assays.
• In vivo, 4-IPITC delayed EAE onset, reduced EAE scores, and showed potential in the MPTP model.

Conclusions:

• 4-IPITC exhibits robust neuroprotective and neurotrophic properties in vitro.
• These findings were corroborated by in vivo studies in models of neurodegeneration.
• 4-IPITC warrants further investigation as a therapeutic agent for neurological disorders.